Analyses of TCGA database samples for DDR1 expression vs. BRAF mutational status showed DDR1 to be slightly upregulated in BRAF-mutated cancers (effect size 0.16, p = 0.00031; differential expression analysis of mutated vs. wild-type cases using a linear model) and with a similar tendency, but not statistically significant, between WT and mutated BRAF melanoma samples (effect size 0.27, p = 0.061, Figure 1A). This evidence concerns the gene DDR1 and melanoma.